提高DCD肝脏利用率和功能的策略
1Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Transplantation
|July 27, 2023
概括
从循环死亡 (DCD) 后的捐赠者中最大限度地进行肝移植,涉及先进的机器输液和像常温区域输液 (NRP) 这样的策略. 这些方法改善了等待移植的患者使用和DCD肝脏全移植的结果.
科学领域:
- 移植免疫学 移植免疫学
- 器官的保存 器官的保存
- 肝病学 肝病学是一种肝病学.
背景情况:
- 循环死亡 (DCD) 之后的捐赠肝脏全移植越来越多地使用,但许多患者仍然在移植等待名单上.
- 优化DCD肝移植的利用和结果对于解决器官短缺至关重要.
研究的目的:
- 审查关于优化DCD肝移植的利用和结果的国际文献.
- 探索改善DCD肝移植的策略,包括供体选择和保存技术.
- 评估先进技术在增加使用高风险捐献器官方面的潜力.
主要方法:
- 关于DCD肝脏全移植优化最新国际文献的综述.
- 分析外科手术期间的策略,包括正常热区域输液 (NRP) 和快速控制的DCD恢复.
- 对扩展标准的捐赠者和机器 perfusion 技术的活力测试的评估.
主要成果:
- 常温和低温机器输液显示了增加DCD器官利用率和改善结果的潜力.
- 欧洲对NRP的广泛经验证明了其在DCD肝移植中的有效性.
- 活力测试和先进的输液技术为使用高风险的捐赠器官提供了有希望的数据.
结论:
- 实施机器输液和NRP等先进技术可以显著提高DCD肝移植的利用率和结果.
- 进一步的研究和在美国采用这些策略可以扩大捐赠者池,并使更多的肝移植等待名单上的患者受益.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16


